356 related articles for article (PubMed ID: 28983627)
1. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated module approach identifies disrupted genes and pathways associated with acute myelocytic leukemia.
Fang Y; Xie LN; Liu XM; Yu Z; Kong FS; Song NX; Zhou F
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4811-26. PubMed ID: 26744873
[TBL] [Abstract][Full Text] [Related]
3. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
4. Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules.
Wang SM; Sun ZQ; Li HY; Wang J; Liu QY
Comput Math Methods Med; 2015; 2015():313740. PubMed ID: 26543493
[TBL] [Abstract][Full Text] [Related]
5. Systematic tracking of altered modules identifies disrupted pathways in teratozoospermia.
Huang ZQ; Wang GX; Jiang XL; Tian EP; Yao WL; Zeng T
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173237
[TBL] [Abstract][Full Text] [Related]
6. Systematic Tracking of Disrupted Modules Identifies Altered Pathways Associated with Congenital Heart Defects in Down Syndrome.
Chen D; Zhang Z; Meng Y
Med Sci Monit; 2015 Nov; 21():3334-42. PubMed ID: 26524729
[TBL] [Abstract][Full Text] [Related]
7. Identifying disrupted pathways by tracking altered modules in type 2 DM-related heart failure.
Liu H; Han X; Li Y
Herz; 2017 Feb; 42(1):98-106. PubMed ID: 27363418
[TBL] [Abstract][Full Text] [Related]
8. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
9. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
10. Systematic tracking of dysregulated modules identifies disrupted pathways in narcolepsy.
Liu Z; Zhao J; Tan Y; Tang M; Li G
Int J Clin Exp Med; 2015; 8(6):9384-93. PubMed ID: 26309600
[TBL] [Abstract][Full Text] [Related]
11. Identification of key biomarkers involved in osteosarcoma using altered modules.
Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
[TBL] [Abstract][Full Text] [Related]
12. Revealing radiotherapy- and chemoradiation-induced pathway dynamics in glioblastoma by analyzing multiple differential networks.
Zhou J; Chen C; Li HF; Hu YJ; Xie HL
Mol Med Rep; 2017 Jul; 16(1):696-702. PubMed ID: 28560382
[TBL] [Abstract][Full Text] [Related]
13. Observation of significant biomarkers in osteosarcoma via integrating module- identification method with attract.
Qi J; Ma L; Wang X; Li Y; Wang K
Cancer Biomark; 2017 Jul; 20(1):87-93. PubMed ID: 28759958
[TBL] [Abstract][Full Text] [Related]
14. Identification of critical genes in nucleus pulposus cells isolated from degenerated intervertebral discs using bioinformatics analysis.
Zhu Z; Chen G; Jiao W; Wang D; Cao Y; Zhang Q; Wang J
Mol Med Rep; 2017 Jul; 16(1):553-564. PubMed ID: 28586059
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis.
Zhang GH; Chen MM; Kai JY; Ma Q; Zhong AL; Xie SH; Zheng H; Wang YC; Tong Y; Lu RQ; Guo L
Gene; 2019 Aug; 709():56-64. PubMed ID: 31108164
[TBL] [Abstract][Full Text] [Related]
16. Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer.
Bapat SA; Krishnan A; Ghanate AD; Kusumbe AP; Kalra RS
Cancer Res; 2010 Jun; 70(12):4809-19. PubMed ID: 20530682
[TBL] [Abstract][Full Text] [Related]
17. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
18. Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma.
Zhang MH; Shen QH; Qin ZM; Wang QL; Chen X
Oncol Lett; 2016 Nov; 12(5):3285-3295. PubMed ID: 27899995
[TBL] [Abstract][Full Text] [Related]
19. Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers.
Sun Q; Zhao H; Zhang C; Hu T; Wu J; Lin X; Luo D; Wang C; Meng L; Xi L; Li K; Hu J; Ma D; Zhu T
Oncotarget; 2017 Jun; 8(26):42983-42996. PubMed ID: 28562334
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
Ayyildiz D; Gov E; Sinha R; Arga KY
OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
